LeMaitre Vascular, Inc.
LMAT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $61,046 | $64,232 | $59,871 | $55,717 |
| % Growth | -5% | 7.3% | 7.5% | – |
| Cost of Goods Sold | $15,091 | $19,258 | $18,451 | $17,127 |
| Gross Profit | $45,955 | $44,974 | $41,420 | $38,590 |
| % Margin | 75.3% | 70% | 69.2% | 69.3% |
| R&D Expenses | $2,970 | $3,541 | $4,095 | $3,618 |
| G&A Expenses | $10,750 | $10,396 | $10,487 | $9,492 |
| SG&A Expenses | $22,673 | $25,291 | $24,699 | $22,118 |
| Sales & Mktg Exp. | $11,923 | $14,895 | $14,212 | $12,626 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $25,643 | $28,832 | $28,794 | $25,736 |
| Operating Income | $20,312 | $16,142 | $12,626 | $12,854 |
| % Margin | 33.3% | 25.1% | 21.1% | 23.1% |
| Other Income/Exp. Net | $2,261 | $1,928 | $1,615 | $1,167 |
| Pre-Tax Income | $22,573 | $18,070 | $14,241 | $14,021 |
| Tax Expense | $5,211 | $4,291 | $3,230 | $2,837 |
| Net Income | $17,362 | $13,779 | $11,011 | $11,184 |
| % Margin | 28.4% | 21.5% | 18.4% | 20.1% |
| EPS | 0.77 | 0.61 | 0.49 | 0.5 |
| % Growth | 26.2% | 24.5% | -2% | – |
| EPS Diluted | 0.75 | 0.6 | 0.48 | 0.49 |
| Weighted Avg Shares Out | 22,660 | 22,614 | 22,570 | 22,506 |
| Weighted Avg Shares Out Dil | 24,392 | 22,892 | 22,899 | 22,902 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,864 | $2,980 | $2,903 | $1,610 |
| Interest Expense | $1,297 | $1,299 | $1,290 | $0 |
| Depreciation & Amortization | $2,613 | $2,648 | $2,552 | $2,478 |
| EBITDA | $26,483 | $22,017 | $18,083 | $20,156 |
| % Margin | 43.4% | 34.3% | 30.2% | 36.2% |